TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2

Yali Fan,Shuya Chen,Chunfang Chu,Xiaodan Yin,Jing Jin,Lingyan Zhang,Huihui Yan,Zheng Cao,Ruixia Liu,Mingwei Xin,Lin Li,Chenghong Yin
DOI: https://doi.org/10.1186/s13048-024-01396-2
2024-03-27
Journal of Ovarian Research
Abstract:Premature ovarian insufficiency (POI) is a severe disorder leading to female infertility. Genetic mutations are important factors causing POI. TP63-truncating mutation has been reported to cause POI by increasing germ cell apoptosis, however what factors mediate this apoptosis remains unclear.
reproductive biology
What problem does this paper attempt to address?
### Problems Addressed by the Paper This paper primarily explores the specific mechanisms by which TP63 gene mutations lead to premature ovarian insufficiency (POI) and seeks potential therapeutic targets. #### Background and Research Objectives - **Background**: Premature ovarian insufficiency (POI) is a severe female infertility condition characterized by the loss of ovarian function in women under 40, leading to infertility and a series of menopausal symptoms. Genetic mutations are considered an important cause of POI. - **Known Information**: Previous studies have shown that truncating mutations in the TP63 gene can lead to POI, but the specific pathways through which they increase apoptosis are not yet clear. - **Research Objectives**: By analyzing 93 POI patient samples through whole-exome sequencing (WES), a 14bp deletion mutation was identified, which causes exon 13 skipping in the TP63 gene, generating a truncated TP63 protein (TP63-mut). Further research found that TP63-mut promotes apoptosis by enhancing the transcriptional activation of the CLCA2 gene, thereby leading to the occurrence of POI. #### Main Conclusions - **Findings**: The TP63-mut protein can bind to the promoter region of the CLCA2 gene, significantly upregulating CLCA2 expression, thereby accelerating apoptosis. - **Mechanism Validation**: Knocking down CLCA2 or inhibiting the ATM pathway can attenuate the apoptosis induced by TP63-mut. - **Potential Therapeutic Target**: CLCA2 may become a potential target for POI treatment. Through these studies, the paper reveals the key role of CLCA2 in the pathogenesis of POI and suggests that CLCA2 may be a potential target for POI treatment.